Clinical Trial Update: Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of KRN7000 for chronic hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• KRN7000 (alpha-galactosylceramide)

Snippet

Sponsor: Foundation for Liver Research | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED